P&G Scoops Consumer Healthcare Unit From Germany’s Merck in First Peltz-era Deal

“Procter & Gamble (PG) agreed Thursday to buy the consumer healthcare unit of Germany’s Merck KGaA (MKGAY) for around $4.2 billion in the first major purchase for the group since activist investor Nelson Peltz won a seat on the board late last year” writes Martin Baccardax for Procter & Gamble will pay €3.4 billion ($4.21 billion) for the division, which includes brands such as Seven Seas and Neurobion vitamins, in a deal that is expected to close in the fourth quarter of this year.

Share This:

Related posts